Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Consultative Hemostasis and Thrombosis
Effectively and efficiently diagnose and manage today's full range of clotting and bleeding disorders using clinical case studies that demonstrate real-world problems and solutions! For each condition examined, you'll review concise descriptions of its associated symptoms, along with laboratory findings, diagnosis, differential diagnosis, and treatment - all the clinical guidance you need - at your fingertips. It's the ideal real-life reference tool for busy physicians! A reader-friendly design, coupled with nearly 385 illustrations and at-a-glance tables - many new to this edition - equip you to quickly locate the guidance you need. Abundant laboratory protocols enable you to select and interpret lab tests more easily. A complete section on women's health issues helps you stay current in this evolving area. A new chapter on the impact of herbal medicines examines their effect on hemostasis and their interaction with other drugs. New coverage of hemostatic issues in traumatology, sepsis, interventional radiology, pulmonology, and cardiology allows you to master the latest advances.
Immunoglobulins
None
Blood Substitutes
This book is not a "proceedings" volume. Rather the chapters are essays by experts in the field of blood substitutes, invited by the editors to con tribute to the 1996 "Current Issues in Blood Substitutes Research and Development" course given in San Diego, March 18-21. The contributors were selected because of their expertise in areas deemed by the editors to be critical to the advancement of the field. The course, as in past years, is heavily influenced by feedback from par ticipants, and by research in this and related fields. In addition to the didactic lectures (for which these chapters are the foundation), the course also offers the opportunity for presentation of research reports, progress reports from the various companies currently commercializing products, and round table discussions of selected subjects. Thus, we are grateful to past participants for their helpful comments. Production of a book, especially on a short timeline, is not an easy feat.
The Bethesda Handbook of Clinical Hematology
Written by clinicians and scientists at the National Institutes of Health and other leading institutions, The Bethesda Handbook of Clinical Hematology, Second Edition is a concise, complete hematology handbook designed for quick bedside consultation. The book covers all hematologic disorders and provides residents, fellows, and practitioners with need-to-know information on pathophysiology, natural history, risk factors, diagnosis, treatment, and follow-up. The succinct yet detailed presentation is ideal for board review as well as clinical reference. This thoroughly updated edition includes new information on supportive care and new therapies, including immunomodulatory drugs, growth factors, and epigenetic-acting agents and their role in selected disorders.
Addressing the Barriers to Pediatric Drug Development
Decades of research have demonstrated that children do not respond to medications in the same way as adults. Differences between children and adults in the overall response to medications are due to profound anatomical, physiological, and developmental differences. Although few would argue that children should receive medications that have not been adequately tested for safety and efficacy, the majority of drugs prescribed for children-50 to 75 percent-have not been tested in pediatric populations. Without adequate data from such testing, prescribing drugs appropriately becomes challenging for clinicians treating children, from infancy through adolescence. Addressing the Barriers to Pediatric Drug Development is the summary of a workshop, held in Washington, D.C. on June 13, 2006, that was organized to identify barriers to the development and testing of drugs for pediatric populations, as well as ways in which the system can be improved to facilitate better treatments for children.
